Rituxan And Multiple Sclerosis

Featured Health Expert
38_8584
EXPERT

Another Warning Label Change: Rituxan Label Changed Again After RA Patient Contracts Brain Infection

On September 11, the FDA, Genentech and Biogen Idec (the manufacturers of Rituxan) announced that the labeling for the drug is being revised.  This comes after the first report that a patient taking Rituxan to treat rheumatoid arthritis had died of the brain infection progressive multifocal leukoencephalopathy (PML).  Rituxan is approved to treat RA and non-Hodgkins Lymphoma.  Several cases of PML have previously been reported in patients taking Rituxan for unapproved, or off-label, uses,...

Read more

More information on "Rituxan And Multiple Sclerosis"

From Our Experts

See more SharePosts »

From Our Sources

More on Multiple Sclerosis »